Clinical Efficacy and Safety of Imidafenacin as Add-on Treatment for Persistent Overactive Bladder Symptoms Despite α-Blocker Treatment in Patients With BPH: The ADDITION STUDY

404 Clinical efficacy and safety evaluation of imidafenacin as add-on treatment for residual overactive bladder symptoms in BPH patients with nocturia; addition study sub-analysis

European Urology Supplements ◽

10.1016/s1569-9056(13)60889-1 ◽

2013 ◽

Vol 12 (1) ◽

pp. e404-e405

Author(s):

M. Gotoh ◽

M. Takeda ◽

O. Nishizawa ◽

M. Yoshida ◽

S. Takahashi ◽

...

Keyword(s):

Overactive Bladder ◽

Clinical Efficacy ◽

Safety Evaluation ◽

Efficacy And Safety ◽

Efficacy and safety of fesoterodine treatment for overactive bladder symptoms in elderly women with and without hypertension

International Journal of Urology ◽

10.1111/iju.13499 ◽

2017 ◽

Vol 25 (3) ◽

pp. 251-257 ◽

Cited By ~ 1

Author(s):

Osamu Yokoyama ◽

Hidetomi Yamagami ◽

Shintaro Hiro ◽

Shinichi Hotta ◽

Masaki Yoshida

Keyword(s):

Overactive Bladder ◽

Elderly Women ◽

Efficacy And Safety ◽

Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration

BJU International ◽

10.1111/j.1464-410x.2010.09359.x ◽

2010 ◽

Vol 106 (9) ◽

pp. 1332-1338 ◽

Cited By ~ 23

Author(s):

Christopher R. Chapple ◽

Sender Herschorn ◽

Paul Abrams ◽

Joseph T. Wang ◽

Marina Brodsky ◽

...

Keyword(s):

Overactive Bladder ◽

Prostate Specific Antigen ◽

Extended Release ◽

Specific Antigen ◽

Efficacy And Safety ◽

Antigen Concentration ◽

Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study

International Neurourology Journal ◽

10.5213/inj.1834982.491 ◽

2018 ◽

Vol 22 (1) ◽

pp. 51-57 ◽

Cited By ~ 3

Author(s):

Hoon Choi ◽

Jae Hyun Bae ◽

Cheol Young Oh ◽

Seong Jin Jeong ◽

Woo Jin Ko ◽

...

Keyword(s):

Diabetes Mellitus ◽

Overactive Bladder ◽

Prospective Study ◽

Clinical Efficacy ◽

Bladder Symptoms ◽

Multicenter Prospective Study

LBA-03 EFFICACY AND SAFETY OF MIRABEGRON VS. PLACEBO ADD-ON THERAPY IN MEN WITH OVERACTIVE BLADDER SYMPTOMS RECEIVING TAMSULOSIN FOR UNDERLYING BENIGN PROSTATIC HYPERPLASIA (PLUS)

The Journal of Urology ◽

10.1097/01.ju.0000557495.41260.09 ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Steven Kaplan* ◽

Sender Herschorn ◽

Kevin McVary ◽

David Staskin ◽

Christopher Chapple ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

UP-03.202 The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms who Poorly Responded to Previous Anticholinergic Agents

Urology ◽

10.1016/j.urology.2011.07.1290 ◽

2011 ◽

Vol 78 (3) ◽

pp. S412

Author(s):

N. Masumori ◽

S. Miyamoto ◽

T. Tsukamoto ◽

S. Furuya ◽

A. Iwasawa ◽

...

Keyword(s):

Overactive Bladder ◽

Efficacy And Safety ◽

Anticholinergic Agents ◽

Efficacy and Safety of Flexible Dose Fesoterodine in Men and Women with Overactive Bladder Symptoms Including Nocturnal Urinary Urgency

The Journal of Urology ◽

10.1016/j.juro.2012.11.067 ◽

2013 ◽

Vol 189 (4) ◽

pp. 1396-1401 ◽

Cited By ~ 34

Author(s):

Jeffrey P. Weiss ◽

Zhanna Jumadilova ◽

Theodore M. Johnson ◽

Mary P. FitzGerald ◽

Martin Carlsson ◽

...

Keyword(s):

Overactive Bladder ◽

Urinary Urgency ◽

Efficacy And Safety ◽

Men And Women ◽

Bladder Symptoms ◽

Flexible Dose

A Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Oxybutynin Vaginal Ring for Alleviation of Overactive Bladder Symptoms in Women

The Journal of Urology ◽

10.1016/j.juro.2013.11.019 ◽

2014 ◽

Vol 191 (4) ◽

pp. 1014-1021 ◽

Cited By ~ 12

Author(s):

Marc Gittelman ◽

Herman Weiss ◽

Larry Seidman

Keyword(s):

Overactive Bladder ◽

Vaginal Ring ◽

Phase 2 ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study)

International Journal of Urology ◽

10.1111/iju.13359 ◽

2017 ◽

Vol 24 (7) ◽

pp. 525-531 ◽

Cited By ~ 11

Author(s):

Tomonori Yamanishi ◽

Hirotaka Asakura ◽

Narihito Seki ◽

Shoji Tokunaga

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Combination Therapy ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Open Label ◽

Direct Study ◽

Clinical efficacy of an α1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia

International Journal of Urology ◽

10.1111/j.1442-2042.2006.01222.x ◽

2006 ◽

Vol 13 (1) ◽

pp. 15-20 ◽

Cited By ~ 37

Author(s):

SATORU TAKAHASHI ◽

ATSUSHI TAJIMA ◽

HISASHI MATSUSHIMA ◽

TAKESHI KAWAMURA ◽

TAKASHI TOMINAGA ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Clinical Efficacy ◽

Prostatic Hyperplasia ◽

Adrenoceptor Blocker ◽